Ethics in artificial intelligence — many questions, but few answers
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment




Artificial Intelligence Homepage

GE and Australian partners to develop AI for brain aneurysm tracking and diagnosis Will prevent brain hemorrhaging

PHDA and Amazon Web Services team up in machine learning healthcare sponsorship Aiming to enhance medical imaging, precision medicine and cancer diagnostics

AI solution distinguishes complex pathologies for accurate breast cancer diagnosis Classify ductal carcinoma in situ from atypia

Half of US hospital leaders surveyed are unfamiliar with premise of AI Less than a quarter are currently seeking to implement it

RadNet acquires Nulogix, opens new AI division Will develop applications for image interpretation

AI could enhance efficiency and accuracy of DBT, says study Can help reduce reading times for DBT

FUJIFILM SonoSite, Partners HealthCare to enhance point-of-care ultrasound with AI partnership Open access to affordable point-of-care ultrasound

Progenics collabs with VA on AI research for prostate cancer treatment Apply machine learning to medical images

AI tool deciphers unstructured data for monitoring tumor changes Just as efficient and faster at extracting data than humans

US leading digital health record adoption, but falls behind elsewhere: Philips report Country rates poorly in use of telemedicine and AI

Ethics in artificial intelligence — many questions, but few answers

by John W. Mitchell , Senior Correspondent

While no conclusions or solutions were reached, the authors appeared to relish the feedback. Key discussion points included:

– There seemed to be support among the mostly clinical and academic audience that sharing patient data is permissible as long as no entity or company profits from the information. However, a few people from AI companies and other commercial interests were quick to point out that medical therapeutic progress is dependent upon shared patient data. The case of Henrietta Lacks, the famous African American woman whose cells powered many important medical discoveries and treatments, was raised as a case study in improper ethics.
Story Continues Below Advertisement


Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.

– Another critical point was the ethics of actionable data. Do researchers have an obligation to follow up with patients whose data clearly indicates a health risk? Ranschaert said that the answer in Europe is yes, based on existing ethical guidelines. There was a discussion that existing IRB research guidelines allow U.S. researchers also to inform patients about a medical threat

– Opt-in and opt-out consent strategies was also a vigorous point of focus. A few participants compared the permission screens that most click through when downloading from a new app or website as useful and adequate in meeting ethical standards for any imaging research.

“We received back hundreds of comments on the paper,” said Gies. "The paper is not perfect, and some people disagree with our conclusions. We're working on trying to reach a lot of people."

The paper can be viewed at:

Back to HCB News
<< Pages: 1 - 2

Artificial Intelligence Homepage

You Must Be Logged In To Post A Comment